9/12 5:30 pm - 8:30 pm
HBA presents 'Putting Academia-Industry Research Partnerships to Work.' Novartis, 1 Health Plaza, East Hanover, NJ more
9/24 4:00 pm - 6:00 pm
CURE presents healthcare investment banker Anthony Gibney of Leerink Swann. Yale Anlyan Center, 300 Cedar Street, New Haven more
10/1 4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Trevi Therapeutics. Anlyan Center, 300 Cedar Street, New Haven. Watch for details.
10/8-9 12th annual BIO Investor Forum. The Palace Hotel, San Francisco more
10/15 6:00 pm - 9:30 pm
HBA presents Women's Healthcare Innovation and Leadership Showcase. Sanofi Campus, 55 Corporate Drive Auditorium, Bridgewater, NJ more
11/7 10:00 am - 3:00 pm
CT Innovation Summit. Mentor meetings, awards ceremony, and more. Co-sponsored by CURE. Oakdale Theater, Wallingford more
11/11-13 The BIO Convention in China. National Convention Center, Beijing more
12/3 5:45 pm - 7:30 pm
CURE Holiday Party. 'The best networking in town.' Café George, 300 George Street, New Haven. Save the Date!

Cost-saving discounts for CURE members!
CURE members can now receive discounts on various products and services, such as lab supplies, shipping services, and gases more

Cheminpharma LLC
25 Science Park at Yale
150 Munson Street
New Haven, CT 08511

Phone: 203-773-1737
Website: http://www.cheminpharma.com

General Information
Connecticut, especially the New Haven area, is home to various biotechnology and pharmaceutical companies surrounding Yale University. Due to the complexity and increasing cost of drug-discovery research, outsourcing a part of research is becoming a normal trend in today's rapidly changing pharmaceutical environment. Therefore, there is a need for a world-class research support company in the region. Cheminpharma intends to fill this gap. Cheminpharma is a drug discovery services company formed by two former Bayer scientists. The founders have twenty-eight years of combined experience in drug discovery research in various therapeutic areas including cancer, diabetes, obesity, osteoporosis, and inflammation. Cheminpharma provides various chemistry based services for preclinical drug discovery to both biotechnology and pharmaceutical companies using their state-of-the art facility. The services include medicinal chemistry services such as hit to lead generation, analog design, lead optimization, building SAR, and structure-based drug design. In addition to medicinal chemistry services, Cheminpharma provides synthesis of intermediates, reference compounds, process impurities etc.

Other Information
CT Employees: 3